Draft Pediatric Acetaminophen Guidance Drills Down With Details To Cut Overdose Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA outlines previous recommendations to reduce the risk of pediatric overdose with acetaminophen products due either to unsupervised ingestion or therapeutic errors, with greater detail on delivery devices and labeling information for pediatric acetaminophen OTCs.
You may also be interested in...
Flow Restrictors Limit Children’s Access To Drugs; Standards Needed
Only 6% of children emptied medicine bottles with flow restrictors in 10 minutes, compared to 82% who emptied bottles with incompletely closed child-resistant caps within two minutes, a CDC study shows. But researchers and stakeholders suggest waiting for industry standards to implement flow restrictors.
Campaign Targets Unsupervised Pediatric Drug Ingestion
The Consumer Healthcare Products Association, the Centers for Disease Control and Prevention and a public-private safe-medication initiative launch the “Up and Away and Out of Sight” campaign to educate caregivers about how to stop curious children from consuming drugs without supervision.
Acetaminophen Awareness Coalition Prepares To Launch Education Campaign
Consumer health advocates, trade groups and FDA representatives are working together to raise awareness of safe acetaminophen use and to address an advisory committee's concerns about the painkiller.